The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Convergent somatic mutations in metabolism genes in chronic liver disease
Open accessAbstract
The progression of chronic liver disease to hepatocellular carcinoma is caused by the acquisition of somatic mutations that affect 20-30 cancer genes 1-8. Burdens of somatic mutations are higher and clonal expansions larger in chronic liver disease 9-13 than in normal liver 13-16, which enables positive selection to shape the genomic landscape 9-13. Here we analysed somatic mutations from 1,590 genomes across 34 liver samples, including healthy controls, alcohol-related liver disease and non-alcoholic fatty liver disease. Seven of the 29 patients with liver disease had mutations in FOXO1, the major transcription factor in insulin signalling. These mutations affected a single hotspot within the gene, impairing the insulin-mediated nuclear export of FOXO1. Notably, six of the seven patients with FOXO1 S22W hotspot mutations showed convergent evolution, with variants acquired independently by up to nine distinct hepatocyte clones per patient. CIDEB, which regulates lipid droplet metabolism in hepatocytes 17-19, and GPAM, which produces storage triacylglycerol from free fatty acids 20,21, also had a significant excess of mutations. We again observed frequent convergent evolution: up to fourteen independent clones per patient with CIDEB mutations and up to seven clones per patient with GPAM mutations. Mutations in metabolism genes were distributed across multiple anatomical segments of the liver, increased clone size and were seen in both alcohol-related liver disease and non-alcoholic fatty liver disease, but rarely in hepatocellular carcinoma. Master regulators of metabolic pathways are a frequent target of convergent somatic mutation in alcohol-related and non-alcoholic fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In NASH livers, Ng et. al. identified convergent mutations in genes central to insulin signaling and lipogenesis6.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The HCC driver genes TP53 (tumor protein p53) and CTNNB1 (catenin beta 1) are not the most frequently observed mutant genes in the cirrhotic liver (7–9), suggesting that these mutations do not drive extensive clonal expansion events before tumor initiation.”
From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“After decades of injury, cirrhotic livers consist of millions of nodules, most of which harbor somatic mutations (7–9).”
From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The HCC driver genes TP53 (tumor protein p53) and CTNNB1 (catenin beta 1) are not the most frequently observed mutant genes in the cirrhotic liver (7–9), suggesting that these mutations do not drive extensive clonal expansion events before tumor initiation.”
From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While this showed that CreER was not 100% efficient, it also faithfully modeled the somatic mosaicism seen in human livers before cancer development (7–9, 33).”
From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [9]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Somatic mutations are common in nonmalignant liver tissues, but mutations in cancer drivers are observed less frequently than anticipated (7–9).”
From The origin of hepatocellular carcinoma depends on metabolic zonation (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These loss of function mutations in metabolic enzymes that generate hepatic lipids suggest that some somatic mutations can confer increased fitness through a reversal of the driving etiology of disease.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This concept was strengthened by the fact that the same mutated genes such as Gpam and Acvr2a were selected for in both mouse and human tissues6.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Interestingly, Acvr2a and Gpam are two of the most recurrently mutated genes in cirrhotic tissues from alcoholic liver disease and NASH patients6.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Mutant clone expansion and recurrent mutations within and between individuals provide compelling evidence for increased mutant clone fitness in chronic liver disease6.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A consistent pattern has been observed across most, if not all, tissues: after an initial expansion of the stem cell pool during early life, clonal heterogeneity tends to diminish over time (Figure 1).17-24”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [24]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Interestingly, these selected and more fit clones may share genomic events such as nonsynonymous mutations initially thought to be restricted to cancer.17-24”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [24]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Examples include the possible links between clonal haematopoiesis and cardiovascular disease54; between mutations in liver disease and insulin resistance55; and between driver mutations in cavernomas and brain haemorrhages49,53,56.”
From Somatic mutation rates scale with lifespan across mammals (2022) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Histological grading and staging of chronic hepatitis.
Ishak, K., Baptista, A., Bianchi, L., Callea, F., Groote, J. D., Gudat, F., Denk, H., Desmet, V., Korb, G., Macsween, R. N., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,290
MCMC Methods for Multi-Response Generalized Linear Mixed Models: The MCMCglmm R Package
Hadfield, J. D. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i02 · Cited by 4,900
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
The repertoire of mutational signatures in human cancer
Alexandrov, L. B., Kim, J., Haradhvala, N. J., Huang, M. N., Tian Ng, A. W., Wu, Y., Boot, A., Covington, K. R., Gordenin, D. A., Bergstrom, E. N., et al. (2020) · Nature · doi:10.1038/s41586-020-1943-3 · Cited by 3,496
Self-citationComprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R. A., Jones, S. J. M., Lee, D., Ma, Y., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.046 · Cited by 2,490
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Self-citationSchulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Self-citation
Cited by
Sorted by citations
Items 101–193 of 193
In vivo selection of hepatocytes
Vonada, A., & Grompe, M. (2024) · Hepatology · doi:10.1097/hep.0000000000001143 · Cited by 8
Gene-based therapies for steatotic liver disease
Iakovleva, V., & de Jong, Y. P. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.024 · Cited by 7
“Additionally, examining somatic mutations that arise in cirrhotic livers recently revealed genes that may protect hepatocytes from SLD. 123 Two of these genes, glycerol-3-phosphate acyltransferase (GPAM) and cell death-inducing DFFA-like effector b (CIDEB) , were subsequently associated to SLD…”
Aging and Aging-Related Senescence in Liver
Ganguly, S., Sakane, S., Hokutan, K., Zhang, V., Miciano, C., Wang, A., Brenner, D. A., & Kisseleva, T. (2025) · Seminars in Liver Disease · doi:10.1055/a-2637-2549 · Cited by 11
Lipid droplets as the genetic nexus of fatty liver
Mann, J. P., Romeo, S., & Valenti, L. V. C. (2022) · Liver International · doi:10.1111/liv.15460 · Cited by 7
Grave-to-cradle: human embryonic lineage tracing from the postmortem body
Choi, S. H., Ku, E. J., Choi, Y. A., & Oh, J. W. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00912-y · Cited by 7
Molecular landscapes of oral cancers of unknown etiologyPreprint
Deneuve, S., Fervers, B., Senkin, S., Bouaoun, L., Pérol, O., Chavanel, B., Lu, L., Coste, I., Renno, T., Zavadil, J., et al. (2023) · medRxiv · doi:10.1101/2023.12.15.23299866 · Cited by 7
Trépo, E., Zucman‐Rossi, J., & Nault, J. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01175-y · Cited by 6
“Recent studies have identified somatic mosaicism in the livers of patients with ALD and MASLD 65,66 (Fig.”
Lee, H. A. (2024) · Ewha Medical Journal · doi:10.12771/emj.2024.e65 · Cited by 5
“Although these genes may help protect hepatocytes from lipotoxicity, they also elevate the risk of malignancy [49,50].”
Russell, C. B., Vettermann, C., Agarwal, S., Witt, E., Clark, W. T., Arens, J., Fronza, R., Obrochta, K. M., Kasprzyk, T., Robinson, T. M., et al. (2025) · Human Gene Therapy · doi:10.1089/hum.2024.236 · Cited by 5
Fu, J., Wei, Y., Yang, Y., Yang, X., Ouyang, T., Wang, X., Chen, S., Liu, Z., Su, Y., Fu, J., et al. (2025) · 癌症：英文版 · doi:10.1002/cac2.70061 · Cited by 6
“The adaptation of hepatocytes to lipotoxicity, along with the generation of reactive oxygen species (ROS) and the activation of DDRs induced by lipid overload, is considered a critical contributor to the tumorigenesis of MASH-related HCC [24, 25].”
Mutational landscape of atherosclerotic plaques reveals large clonal cell populations
Steffensen, L. B., Kavan, S., Jensen, P. S., Pedersen, M. K., Bøttger, S. M., Larsen, M. J., Dembić, M., Bergman, O., Matic, L. P., Hedin, U., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.188281 · Cited by 7
Clinical value of identifying genes that inhibit hepatocellular carcinomas
Testa, U., Pelosi, E., & Castelli, G. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2154658 · Cited by 5
Evo-devo perspectives on cancer
Nedelcu, A. M. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220041 · Cited by 6
Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skinPreprint
Ólafsson, S., Rodríguez, E., Lawson, A. R. J., Abascal, F., Jones, P. H., Gerdes, S., Martincorena, I., Weidinger, S., Campbell, P. J., & Anderson, C. A. (2022) · medRxiv · doi:10.1101/2022.07.04.22277086 · Cited by 5
Self-citationCollateral mutagenesis funnels multiple sources of DNA damage into a ubiquitous mutational signaturePreprint
Spisak, N., de Manuel, M., & Przeworski, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.28.672844 · Cited by 8
“…analyze available non-cancerous datasets where mutations were identified either in single cells [47] or in small clusters of closely related cells [52– 54], focusing on single base substitutions, the mutation type that can be most reliably detected in the short-read sequencing data used in these…”
Somatic mutations in TBX3 promote hepatic clonal expansion by accelerating VLDL secretion
Mannino, G., Quinn, G., Zhu, M., Wang, Z., Wang, X., Li, B., Hsieh, M.-H., Mathews, T., Zacharias, L., Gu, W., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191855 · Cited by 4
“Genomic sequencing of liver tissues from MASLD and alcohol-related liver disease patients identified somatic mutations in TBX3 (10), several of which fell within the T-box DNA-binding domain (Figure 1C), indicating that TBX3 mutations may also promote clonal expansion in human disease.”
Self-citationWang, J., Ren, K., Wang, X., Zhang, S., & Zhao, J. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-04139-9 · Cited by 4
“A study by Ng published in Nature demonstrated that a mutation at the FOXO1 S22 locus blocks insulin-mediated nuclear export (dependent on AKT phosphorylation) in a chronic liver disease model, resulting in the sustained accumulation of FOXO1 in the nucleus and activation of metabolic genes [111].”
Huang, A. Y., Cheng, Y., Ku, J., Zhao, B., Park, J., Kim, D., Choi, J., & Lee, E. A. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1450 · Cited by 4
“…pool [ 84 ], allowing these variant-carrying clones to be captured in bulk RNA-seq data, whereas liver clones are more focal and spatially restricted [ 85 ], resulting in a lower likelihood of detection by conventional bulk tissue sequencing used in GTEx, unless clones are carefully microdissected.”
Somatic genomics as a discovery engine for biomedicine
Brunner, S. F., Martincorena, I., Mannino, G., Fox, C. S., Stratton, M. R., Rubens, J. R., Campbell, P. J., & Zhu, H. (2026) · Cell · doi:10.1016/j.cell.2026.01.032 · Cited by 9
“The observation that loss-of-function mutations in lipid metabolism genes such as GPAM and CIDEB and hotspot mutations in FOXO1 are enriched in MASLD 21 suggests that some somatic mutations confer increased fitness through disrupting lipogenesis pathways.”
InfluentialSelf-citationLuijts, T., Elliott, K., Siaw, J. T., de Velde, J. V., Beyls, E., Claeys, A., Lammens, T., Larsson, E., Willaert, W., Vral, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14240-8 · Cited by 6
Demystifying the black box: from ignorance to observation to mechanism in cancer research
Campbell, P. J. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00935-9 · Cited by 4
“…obesity-associated chronic liver disease have convergent somatic mutations in master regulators of lipid metabolism in individual cirrhotic nodules [16] – intriguingly, different genes tend to be mutated in different patients, and understanding what dietary or metabolic factors shape these…”
Self-citationSomatic mutations reveal clonal cell populations in atherosclerotic plaquesPreprint
Steffensen, L. B., Kavan, S., Jensen, P., Møller‐Larsen, S., Larsen, M. L., Dembić, M., Andersen, L., Lindholt, J. S., Houlind, K. C., Thomassen, M., et al. (2022) · medRxiv · doi:10.1101/2022.05.16.22275001 · Cited by 4
Miyake, T., Yoshida, O., Furukawa, S., Sato, Y., Murakami, Y., Kanamoto, A., Miyazaki, M., Shiomi, A., Nakaguchi, H., Koizumi, M., et al. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02297-x · Cited by 3
Computational Analysis and Molecular Docking Approach for Liver Cancer
Kumari, U., & Tripathi, K. (2023) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2023.54927 · Cited by 3
The etiology of clonal mosaicism in human aging and disease
Massaar, S., & Sanders, M. A. (2023) · Aging and Cancer · doi:10.1002/aac2.12061 · Cited by 4
Self-citationVEXAS: is it time to reshape the nosology of clonal hematopoiesis?
Sujobert, P., Largeaud, L., Jamilloux, Y., Heiblig, M., & Kosmider, O. (2023) · Expert Review of Hematology · doi:10.1080/17474086.2023.2209715 · Cited by 3
“However, the link between organ dysfunction and clonal evolution has also been described in other solid organs [41,42].”
BackgroundHe, Q., Yao, W., Wu, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011318 · Cited by 3
Chung, A., Guo, J., Wang, Y., Jia, Y., Corbitt, N., Li, L., Wei, Y., Zhu, M., Wang, Z., Guo, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.10.575013 · Cited by 3
Chavanel, B., Tibaldi, E., Virard, F., Carreira, C., Senkin, S., Abedi‐Ardekani, B., Cahais, V., Korenjak, M., Herceg, Z., Balbo, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.01.673482 · Cited by 3
Harnessing genomics for early cancer detection, risk stratification and prevention
Gu, M., Zhang, W. Z., Fitzgerald, R. C., Frankell, A. M., & Vassiliou, G. S. (2026) · Nature Genetics · doi:10.1038/s41588-026-02505-1 · Cited by 4
Colitis-Associated Carcinoma: The Quintessential Epithelial Neoplasia Driven by Chronic Inflammation
Drage, M. G., & Mino-Kenudson, M. A. (2026) · Cells · doi:10.3390/cells15050481 · Cited by 2
“Convergent evolution in somatic tissues has been observed in other settings [73], and appears to be a reproducible feature of chronically injured mammalian tissue, suggesting a strong context-dependent selection for pathway-specific alterations.”
Deneuve, S., Fervers, B., Bruno, J. S., Bach, E., Senkin, S., Goldman‐Lévy, G., Carreira, C., Laklouk, I. A., Hu, R., Bouaoun, L., et al. (2026) · International Journal of Oral Science · doi:10.1038/s41368-026-00437-4 · Cited by 2
A single-cell lens into the co-evolution of genotypes and phenotypes in cancer
Izzo, F., Prieto, T., Potenski, C. J., & Landau, D. A. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00970-8 · Cited by 2
Diabetes treatment by conversion of gut epithelial cells to insulin‐producing cells
Accili, D., Talchai, S. C., Bouchi, R., Lee, A. Y., Du, W. J., Kitamoto, T., McKimpson, W. M., Belvedere, S., & Lin, H. V. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14175 · Cited by 2
Bulatova, I. A., Shevlyukova, T. P., Щекотова, А. П., & Вячеславовна, П. С. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-214-6-47-52 · Cited by 2
Li, J., Cao, F., & Zhang, H. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106025 · Cited by 2
Mechanistic basis for protection against fatty liver disease by CIDEB loss-of-function mutationsPreprint
Zeng, Q., Patel, S., Wang, X., Hsieh, M.-H., Li, Z., Ren, X., Wang, J., Kim, D., Li, S., Gu, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646492 · Cited by 2
Self-citationExtensive and differential platinum chemotherapy mutagenesis in childrenPreprint
Wenger, A., Lee-Six, H., Dave, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.12.681852 · Cited by 2
Self-citationBenchmarking of duplex sequencing approaches to reveal somatic mutation landscapesPreprint
Zhang, Y., Viswanadham, V., Andreopoulos, M., Głodzik, D., Liu, R., Luquette, L. J., Jo, S., Narayan, A., Niu, M., Anderson, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.12.692823 · Cited by 4
Self-citationAberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors
Nishikawa, Y. (2024) · Pathology International · doi:10.1111/pin.13441 · Cited by 1
Liu, N., Zeng, H., Cai, X., Yang, S., Chen, X., Jiang, G., Yuan, J., Cai, J., & Zhou, H. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1654501 · Cited by 1
Somatic mutations impose an entropic upper bound on human lifespan
Efimov, E., Fedotov, V., Malaev, L. G., Khrameeva, E. E., & Kriukov, D. V. (2026) · npj Aging · doi:10.1038/s41514-026-00421-6 · Cited by 2
Somatic mutations and clonal evolution in normal tissues and cancer development
Yoshida, K. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01592-0 · Cited by 4
“In chronic liver diseases, such as alcohol-related liver disease and nonalcoholic fatty liver disease, hepatocytes acquire mutations in metabolic-related genes, such as FOXO1 , CIDEM and GPAM1 , which may protect against lipotoxicity 82 .”
Zhan, Z., Liu, X., Li, Z. H., Qiao, X., Li, S., Gong, Y., Yang, L., Gao, Y., Xia, X., Bai, K., et al. (2026) · Science Advances · doi:10.1126/sciadv.aef1896 · Cited by 1
Adaptive oncogenesis of β-catenin emerges from declining liver tissue integrity
Illendula, A., Hewett, C. K., Hayata, Y., Strathearn, L. S., He, G., Carballo-Botinas, L., Navas-Sanz, S., Niqui-Capdevila, M., Garcia-Santos, A., Bernabé-Pérez, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76373-y · Cited by 1
“This negative selection model provides a potential explanation for the scarcity of CTNNB1 mutations in the normal healthy human liver 2,48 .”
Extensive and differential platinum chemotherapy mutagenesis in livers of children
Wenger, A., Vannier, J., Lee-Six, H., et al. (2026) · Science · doi:10.1126/science.ady0339 · Cited by 1
Self-citationFatty Acid Esterification as a NASH Therapeutic Target
Sakuma, I., & Vatner, D. F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.10.011 · Cited by 1
“7 Ng et al 8 observed somatic missense, nonsense, and frameshift mutations of GPAM in biopsy specimens of liver from patients with NAFLD and alcohol-related liver disease.”
BackgroundMbabazi, J., MacGregor, F., Breckon, J. D., Tolchard, B., Watson, D. J., Hogg, J., Kunonga, E., Nalweyiso, D. I., Teke, J., Dawson, R., et al. (2024) · Cogent Public Health · doi:10.1080/27707571.2023.2294518 · Cited by 1
Unveiling the Multifaceted Role of CIDEB: From Apoptosis to Lipid Metabolism and Liver Health
Wutsdorff, L., Mougnekabol, J., Tang, P., Reutzel‐Selke, A., Sauer, I. M., & Haep, N. (2024) · Livers · doi:10.3390/livers4030030 · Cited by 1
The interplay between germline and somatic variants in alpha-1 anti-trypsin deficiency liver disease
Vilarinho, S. (2025) · Nature Genetics · doi:10.1038/s41588-025-02151-z · Cited by 1
Healthy lifestyle? or just the right genetic mutations
Butera, A., & Amelio, I. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2206351 · Cited by 1
“Overall, this study demonstrates that some rare nucleotide variants found in the human genome can have a strong protective effect against the development of diseases [15,16].”
BackgroundLuijts, T., Elliott, K., Siaw, J. T., de Velde, J. V., Beyls, E., Claeys, A., Lammens, T., Larsson, E., Willaert, W., Vral, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.27.482170 · Cited by 1
Mohiuddin, M., Marušić, Z., Aničić, M., Dijck, A. V., Cappuyns, E., Rizzuti, L., Vitriolo, A., Hacohen-Kleiman, G., Grigg, I., Testa, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.21.496616 · Cited by 1
“In humans, accumulation of de novo mutations can arise in differentiated hepatocytes with high spontaneous mutation frequencies in that significantly increase with age(80,84).”
BackgroundAccurate de novo detection of somatic mutations in high-throughput single-cell profiling data setsPreprint
Muyas, F., Li, R., Rahbari, R., Mitchell, T. J., Hormoz, S., & Cortés‐Ciriano, I. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.22.517567 · Cited by 1
Self-citationLiu, S., Yu, Y., Ren, B., et al. (2023) · doi:10.7554/elife.87607.2 · Cited by 1
Cutler, R. R., Heid, J., Sun, S., Lee, M., Maslov, A. Y., Zhang, L., Sidoli, S., Dong, X., & Vijg, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.07.588286 · Cited by 1
Brzozowska, N., Wu, L., Khodzhaeva, V., Griffiths, W. J., Duckworth, A., Jung, H., Coorens, T. H. H., Hooks, Y. E., Chambers, J. E., Campbell, P. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.02.610686 · Cited by 1
“…on MASLD and alcohol-related liver disease, we identified convergent evolution of functional variants in metabolism genes, including FOXO1, CIDEB and GPAM , that drive clonal hepatocyte expansion, likely through modulation of carbohydrate and lipid metabolism 4 , known to be dysregulated in MASLD.”
BackgroundSelf-citationGermline and somatic variation influence nuclear-mitochondrial crosstalk in tumourigenesisPreprint
Daunesse, M., Sundaram, V., Kentepozidou, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.11.637769 · Cited by 1
Self-citationThe eternal quest for self-improvement of somatic cells
Campbell, P. J. (2022) · Cell Genomics · doi:10.1016/j.xgen.2022.100094
Self-citationTumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Yu, J., & Pajvani, U. B. (2022) · Medical Review · doi:10.1515/mr-2022-0043
Liu, S., Yu, Y., Ren, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.16.532991
Somatic mutant clone screening: scan for novel NASH target genes in mouse liver
Lan, T., Guillot, A., & Tacke, F. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01572-8
“It has been suggested that somatic mutations are an adaptive mechanism that renders the mutated cells (partially) resistant to insults.(2) Therefore, MOSAICS as an experimental approach to screen for somatic mutations that protect cells from metabolic injury in NAFLD could be valuable to uncover potential therapeutic…”
BackgroundLiu, S., Yu, Y.-P., Ren, B.-G., et al. (2023) · doi:10.7554/elife.87607.2.sa1
Assante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153149
Self-citationAssante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153146
Self-citationAssante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A. K., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153140
Self-citationHost physiology shapes the mutational landscape of normal and carcinogenic tissue
Nasreddin, N., & Sansom, O. J. (2024) · Nature Genetics · doi:10.1038/s41588-024-01922-4
Zhang, C., Yang, D., Suzuki, H., Chen, J., Wang, J., Ye, M., Zhou, J., Zeng, Q., Bai, M., Lin, M.-J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.20.655199
The Role of Clinical Chemistry in Early Detection of Liver Disorders
Abd, F. F., Jabar, Z. A. H., Kadhim, A. J. A. A., Hussein, S. M., & Abbas, Z. O. (2025) · Bright Sky Publications eBooks · doi:10.62906/bs.book.390
Epithelial state-transitions permit inflammation-induced tumorigenesisPreprint
Jarman, E. J., Lyons, A. M., Yao, Y., Rozyczko, A., Waddell, S. H., Grãdinaru, A., Olaizola, P., Davies, K., Guest, R. V., Roessler, S. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.22.660911
YAP/TAZ-driven cell competition in early MASLD as a tumor-suppressive mechanism
López-Pascual, A., Fernández‐Barrena, M. G., & Avila, M. A. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.07.009
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563953
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563947
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563956
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563965
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563950
Assante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153143
Self-citationChen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563959
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563962
Interorganelle competition for linoleic acid underlies steatotic liver pathologyPreprint
Zhang, C., Yang, D., Suzuki, H., DiasdoVale, G., Chen, J., Vaidya, A., Melikov, K., Swisher, A. E., Wang, J., Ye, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.11.698890
Jeong, Y. J., Song, I.-S., & Jang, S.-W. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02676-7
Perdomo, S. P., de Carvalho, A. C., Ferreiro-Iglesias, A., Pinto, L. F. R., Shibata, T., & Brennan, P. (2026) · JNCI Monographs · doi:10.1093/jncimonographs/lgaf045
Genetic testing in liver diseases: Clinical applications
Keitel, V., Mentzinger, A., Dröge, C., & Vilarinho, S. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101902
“66 69 For example, rare germline mutations in CIDEB , which encodes a structural protein in hepatic lipid droplets, are associated with 33% lower odds of liver disease from any cause.”
Arora, K., Chowdhary, R., McNulty, R., Chowdhary, R., Aleyadeh, W., Patel, M., & Singh, A. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01795-2
“While this adaptation ensures cell survival in lipid laden hepatocytes, it worsens metabolic dysfunction in MASLD [29].”
Understanding the somatic evolution of metabolic traits
Khandelwal, R., & Sharma, A. K. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01551-7
Effects of ethanol and acetaldehyde on multi-organ genomic mutation landscapes
Chavanel, B., Tibaldi, E., Virard, F., Carreira, C., Senkin, S., Abedi‐Ardekani, B., Cahais, V., Korenjak, M., Herceg, Z., Balbo, S., et al. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10217-9 · Cited by 3
Mascardi, M. F., Taussig, R., Signoretta, I. P., Suarez, B., Marciano, S., Casciato, P. C., Narvaez, A., Haddad, L., Gadano, A. C., Steinhardt, A. P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.30.735597
Beyond Fat: Reframing MASLD Through Genetics, Clonal Biology, and Precision Hepatology
Crespo, J., Alonso‐Peña, M., Jiménez-González, C., Cayon, L., & Iruzubieta, P. (2026) · Pharmaceuticals · doi:10.3390/ph19081145
“It is also possible that modulation of a single hepatocellular pathway becomes inadequate once disease progression incorporates systemic inflammation, fibrotic remodeling, and acquired clonal adaptation.”
InfluentialSomatic mutations in human ontogenesis and their impact on health
Sergeyev, O., Ашапкин, В., Korostin, D. O., Bezuglov, V., Suvorov, A., Rebrikov, D., & Chernykh, V. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103338
Cai, L.-Y., Guan, Y., Hu, J., Sun, C.-Y., Ding, C., Zhang, X., Zeng, X., & Xie, W. (2026) · Liver International · doi:10.1111/liv.70846
“ACSL4 catalyses long-chain fatty acids (LCFAs) to acyl-CoA for the synthesis of cellular lipids, and GPAM is the rate-limiting enzyme in the conversion of FAs to storage triglycerides [17, 18].”
Biological age uncertainty reveals discordant aging and predicts human healthspanPreprint
Li, Y., Feng, G., Yan, S., Huang, Q., Jin, J., Wang, Y., Pei, Z., Tay, L. X., Li, K., Yuan, Z., et al. (2026) · medRxiv · doi:10.64898/2026.09.26.26364091
Beyond fibrosis: the molecular roadmap from MASLD to hepatocellular carcinoma
Nevi, L., Altomare, A., Gallo, P., Taffon, C., Musarra, T., Baiocchini, A., & Carotti, S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1933386
Spatial metabolism uncouples clonal fitness from liver cancer initiation
Wan, K., Tang, K., Tian, Q., et al. (2026) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2026.103
Metadata
- Authors
- Ng, S. W. K., Rouhani, F. J., Brunner, S. F., Brzozowska, N., Aitken, S. J., Yang, M., Abascal, F., Moore, L., Nikitopoulou, E., Chappell, L., Leongamornlert, D., Ivovic, A., Robinson, P., Butler, T., Sanders, M. A., Williams, N., Coorens, T. H. H., Teague, J., Raine, K., Butler, A. P., Hooks, Y., Wilson, B., Birtchnell, N., Naylor, H., Davies, S. E., Stratton, M. R., Martincorena, I., Rahbari, R., Frezza, C., Hoare, M., & Campbell, P. J.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Erasmus MC (NL)
- Addenbrooke's Hospital (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Hoare, Matthew
- Campbell, Peter J.
- ORCID
- Ng, Stanley W. K.
- Rouhani, Foad J.
- Brunner, Simon F.
- Brzozowska, Natalia
- Aitken, Sarah J.
- Yang, Ming
- Abascal, Federico
- Moore, Luiza
- Nikitopoulou, Efterpi
- Chappell, Lia
- Leongamornlert, Daniel
- Ivovic, Aleksandra
- Robinson, Philip
- Butler, Timothy
- Sanders, Mathijs A.
- Williams, Nicholas
- Coorens, Tim H. H.
- Teague, Jon
- Raine, Keiran
- Naylor, Huw
- Davies, Susan E.
- Stratton, Michael R.
- Martincorena, Iñigo
- Rahbari, Raheleh
- Frezza, Christian
- Hoare, Matthew
- Campbell, Peter J.
- Venue
- Nature
- Published
- 2021-10-13
- Volume
- 598
- Issue
- 7881
- Pages
- 473-478
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3206615564
- Cited by
- 190
- References
- 54
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 46 · 2023: 41 · 2022: 31 · 2021: 2
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- European Hematology Association (TRTH182)
- Wellcome Trust
- Cancer Research UK (26813, 29681, 19924, C14303 / A17197, 21777, 24032, 22310, 27114)
- National Institute for Health and Care Research (CL-2019-14-003, CL-2016-14-004)
- Academy of Medical Sciences (SGL019\1092)
- Medical Research Council (MC_UU_12022/6)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- somatic mutations, convergent evolution, chronic liver disease, hepatocellular carcinoma, FOXO1, CIDEB, GPAM, metabolic genes, alcoholic liver disease, non-alcoholic fatty liver disease, clonal expansion, driver mutations, insulin signaling, lipid droplet metabolism, triglyceride synthesis
- MeSH terms
- Forkhead Box Protein O1, Chronic Disease, Fatty Acids, Nonesterified, Female, Humans, Insulin Resistance, Liver, Liver Diseases, Liver Diseases, Alcoholic, Male, Mutation, Triglycerides, Cohort Studies, Active Transport, Cell Nucleus, Cell Line, Tumor, Apoptosis Regulatory Proteins, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
